Perrigo Israel Pharmaceuticals Ltd. – Trademark Portfolio
Entity Type: 16
Perrigo Israel Pharmaceuticals Ltd. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CENTANY. The owner is based in Bnei Brak.
29 Lehi Street
Bnei Brak 51200 , IL
Showing of trademarks Trademarks
Trademark Classifications
Perrigo Israel Pharmaceuticals Ltd.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Perrigo Israel Pharmaceuticals Ltd. have?
Perrigo Israel Pharmaceuticals Ltd. has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned, 3 cancelled.
What trademark classes does Perrigo Israel Pharmaceuticals Ltd. file in?
Perrigo Israel Pharmaceuticals Ltd. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Perrigo Israel Pharmaceuticals Ltd.'s most well-known trademarks?
Perrigo Israel Pharmaceuticals Ltd.'s registered trademark portfolio includes well-known marks such as CENTANY. These are among 1 currently registered trademark in the portfolio.
What is Perrigo Israel Pharmaceuticals Ltd.'s trademark registration success rate?
Perrigo Israel Pharmaceuticals Ltd. has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.